raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:314662

Segmental progressive overgrowth syndrome with fibroadipose hyperplasia

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Antenatal, Neonatal
Status
active

A rare <i>PIK3CA</i>-related overgrowth syndrome disease characterized by segmental and progressive overgrowth, predominantly involving the adipose tissue, or a mixture of adipose and fibrous tissue, with variable involvement of subcutaneous and muscular tissue, as well as skeletal overgrowth. Overgrowth severity and range is highly variable, although frequently it is asymmetric and disproportionate, it affects lower extremities more than the upper ones, and progresses in a distal to proximal pattern. Congenital overgrowth is typically associated.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enSegmental progressive overgrowth syndrome with fibroadipose hyperplasia
frSyndrome de croissance segmentaire progressive avec hyperplasie fibroadipeuse
deSegmental-progressives Großwuchs-Syndrom mit fibroadipöser Hyperplasie
esSíndrome de sobrecrecimiento segmentario progresivo con hiperplasia fibroadiposa
itSindrome da iperaccrescimento segmentale progressivo con iperplasia fibroadiposa
nlSegmentaal progressief overgroeisyndroom met fibroadipose hyperplasie
ptSíndrome de sobrecrescimento progressivo segmentar com hiperplasia fibroadiposa
plZespół odcinkowego przerostu postępującago z hiperplazją włóknisto-tłuszczową
csSegmentální progresivní syndrom nadměrného vzrůstu s fibroadipózní hyperplázií
ukСиндром сегментарного прогресуючого розростання з фіброадипозною гіперплазією
zh节段进行性过度生长综合征伴纤维脂肪增生
trFibroadipoz hiperplazi ile seyreden segmental ilerleyici aşırı büyüme sendromu

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10Q87.3NTBTattributedvalidated
MONDO0017812Evalidated
UMLSC5192432Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
PIK3CADisease-causing somatic mutation(s) inAssessedHGNC:8975ENSG000001218791718343q26.32phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha22729222[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families10 casesWorldwideCase(s)Validated22729222[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

14 annotations · validated 2024-02-05
HPOTerm (as annotated by Orphanet)Diagnostic
Obligate (100%)
HP:0001548Overgrowth
Frequent (79-30%)
HP:0025104Capillary malformation
HP:0100774Hyperostosis
HP:0009126Increased adipose tissue
HP:0100578Lipoatrophy
HP:0012032Lipoma
HP:0011276Vascular skin abnormality
Occasional (29-5%)
HP:0002019Constipation
HP:0012725Cutaneous syndactyly
HP:0010816Epidermal nevus
HP:0030424Epididymal cyst
HP:0000034Hydrocele testis
HP:0100559Lower limb asymmetry
HP:0010442Polydactyly

Run the differential on the 1 obligate / very frequent terms

Annotation source: 22729222[PMID]_23946963[PMID]

7

Sources for this card